TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice
TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice is a paper indexed in ScholarIQ from OpenAlex.
How many citations does TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice have?
TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice has 78 citations in the OpenAlex counts ScholarIQ stores.
When was TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice published?
TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice has 2012 year in the ScholarIQ index.
What is the open-access status of TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice?
TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice has bronze oa status in the ScholarIQ index.
What is the DOI of TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice?
The DOI for TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice is on the source record.
What is the PMID of TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice?
The PMID for TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice is on the source record.
What is the OpenAlex record for TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice?
The OpenAlex for TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice is on the source record.